Precision BioSciences (DTIL) Earnings Date, Estimates & Call Transcripts $10.30 -0.19 (-1.81%) (As of 09/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 5EstimatedActual EPS (Aug. 1) $3.46 Beat By $4.23 Consensus EPS (Aug. 1) -$0.77 Conference Call TranscriptConference Call Audio Get Precision BioSciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for DTIL and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDTIL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DTIL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Precision BioSciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241($0.77)($0.77)($0.77)Q3 20241($0.79)($0.79)($0.79)Q4 20241($0.43)($0.43)($0.43)20243($1.99)($1.99)($1.99)Q1 20251($0.39)($0.39)($0.39)Q2 20251($0.07)($0.07)($0.07)Q3 20251($0.33)($0.33)($0.33)Q4 20251($0.26)($0.26)($0.26)FY 20254($1.05)($1.05)($1.05)DTIL Earnings Date and InformationPrecision BioSciences last issued its earnings data on August 1st, 2024. The reported $3.46 earnings per share for the quarter, topping analysts' consensus estimates of ($0.77) by $4.23. The firm had revenue of $49.90 million for the quarter, compared to analyst estimates of $8.50 million. Precision BioSciences has generated ($7.47) earnings per share over the last year (($7.47) diluted earnings per share). Earnings for Precision BioSciences are expected to decrease in the coming year, from $0.82 to ($1.06) per share. Precision BioSciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off prior year's report dates.Read More Precision BioSciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/5/2024(Estimated)------- 8/1/2024Q2 2024($0.77)$3.46+$4.23$2.25$8.50 million$49.90 million 5/13/2024Q1 2024($0.45)($0.35)+$0.10($2.40)$9.35 million$17.58 million3/27/2024Q4 2023$3.00($3.35)($6.35)($2.64)$28.50 million$7.04 million11/7/2023Q3 2023($5.70)($3.00)+$2.70($0.13)$7.50 million$13.12 million8/4/2023Q2 2023($6.90)($3.00)+$3.90($0.10)$6.58 million$19.79 million5/9/2023Q1 2023($6.60)($6.90)($0.30)($0.23)$6.58 million$8.78 million Get the Latest News and Ratings for DTIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Precision BioSciences and its competitors with MarketBeat's FREE daily newsletter. 3/9/2023Q4 2022($7.20)($7.80)($0.60)($0.26)$5.95 million$10.60 million11/8/2022Q3 2022($10.50)($6.60)+$3.90($0.22)$5.37 million$7.36 million8/8/2022Q2 2022($12.90)($13.20)($0.30)($0.42)$5.01 million$3.82 million5/9/2022Q1 2022($17.40)($13.80)+$3.60($0.46)$5.00 million$3.32 million3/15/2022Q4 2021($14.40)($11.40)+$3.00($0.38)$8.24 million$6.34 million11/10/2021Q3 2021($17.70)($5.70)+$12.00($0.19)$8.54 million$24.04 million8/11/2021Q2 2021($13.20)$10.80+$24.00$0.36$22.74 million$68.81 million5/12/2021Q1 2021($15.00)($9.90)+$5.10($0.33)$8.77 million$16.35 million 3/17/2021Q4 2020($15.00)($13.20)+$1.80($0.44)$3.73 million$8.85 million11/15/2020Q3 2020($19.80)($15.00)+$4.80($0.50)$4.25 million$7.36 million 8/13/2020Q2 2020($17.70)($18.90)($1.20)($0.63)$5.62 million$1.08 million5/15/2020Q1 2020($15.90)($15.60)+$0.30($0.52)$5.20 million$7.00 million 3/10/2020Q4 2019($15.30)($10.80)+$4.50($0.36)$9.56 million$6.52 million11/12/2019Q3($16.80)($12.30)+$4.50($0.41)$5.25 million$4.87 million Precision BioSciences Earnings - Frequently Asked Questions When is Precision BioSciences's earnings date? Precision BioSciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates. Learn more on DTIL's earnings history. Did Precision BioSciences beat their earnings estimates last quarter? In the previous quarter, Precision BioSciences (NASDAQ:DTIL) reported $3.46 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.77) by $4.23. Learn more on analysts' earnings estimate vs. DTIL's actual earnings. How can I listen to Precision BioSciences's earnings conference call? The conference call for Precision BioSciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Precision BioSciences's conference call transcript? The conference call transcript for Precision BioSciences's latest earnings report can be read online. Read Transcript How much revenue does Precision BioSciences generate each year? Precision BioSciences (NASDAQ:DTIL) has a recorded annual revenue of $87.64 million. How much profit does Precision BioSciences generate each year? Precision BioSciences (NASDAQ:DTIL) has a recorded net income of -$61.32 million. DTIL has generated -$7.47 earnings per share over the last four quarters. What is Precision BioSciences's EPS forecast for next year? Precision BioSciences's earnings are expected to decrease from $0.82 per share to ($1.06) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Cellectis Earnings Date Sangamo Therapeutics Earnings Date Biomea Fusion Earnings Date Adaptimmune Therapeutics Earnings Date Heron Therapeutics Earnings Date Nkarta Earnings Date Acrivon Therapeutics Earnings Date uniQure Earnings Date scPharmaceuticals Earnings Date MeiraGTx Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:DTIL) was last updated on 9/14/2024 by MarketBeat.com Staff From Our PartnersMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Turn Smartphones Into “Earnphones”?High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportu...Mode Mobile | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredWhy Institutions Are Bullish on BitcoinThe recent dip in the crypto market might be stressful… But it also presents a tremendous opportunity for s...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.